Ligand profile
CHEMBL2289491
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_02514 — 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL2289491- UniProt (similar protein)
P69834- pchembl
- 6.850 (~141.3 nM)
- Target protein
- KP13_02514
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 63.3
- −1 ≤ LogP ≤ 5 2.07
- MW ≤ 500 Da 260.7
- LogP ≤ 5 2.07
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 63.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Oc1c(Cc2ccccc2)c(Cl)nc2ncnn12Oc1c(Cc2ccccc2)c(Cl)nc2ncnn12
InChI=1S/C12H9ClN4O/c13-10-9(6-8-4-2-1-3-5-8)11(18)17-12(16-10)14-7-15-17/h1-5,7,18H,6H2InChI=1S/C12H9ClN4O/c13-10-9(6-8-4-2-1-3-5-8)11(18)17-12(16-10)14-7-15-17/h1-5,7,18H,6H2
AFMPXANNRQOFLA-UHFFFAOYSA-NAFMPXANNRQOFLA-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Binding sites
- PF01128
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL2289491 →
- UniProt UniProt P69834 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL2289491”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02514.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 5
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).